Participant Database for Autism Research Studies

This study is currently recruiting participants.

Verified by Massachusetts General Hospital, September 2009

First Received: October 15, 2007 Last Updated: September 25, 2009 History of Changes

Sponsor:	Massachusetts General Hospital
Information provided by:	Massachusetts General Hospital
ClinicalTrials.gov Identifier:	NCT00549731

Purpose

The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.

Condition
Autism Spectrum Disorder Developmental Language Disorders

Study Type:	Observational
Study Design:	Case Control, Prospective
Official Title:	Participant Database for Persons Interested in Autism Research Studies: Recruiting, Pre-Screening and Diagnostic Assessment

Resource links provided by NLM:

MedlinePlus related topics: Autism

U.S. FDA Resources

Further study details as provided by Massachusetts General Hospital:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	5000
Study Start Date:	June 2005
Estimated Study Completion Date:	June 2010
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)

Detailed Description:

Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities

Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group

Aim 3: to maintain subject information in a database, from which we can recruit for our studies

Eligibility

Ages Eligible for Study:	up to 45 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Adult/Pediatric

Criteria

Inclusion Criteria:

Enrollment will be open to typically-developing, healthy children and adults (ages 0-45), children and adults with autism spectrum disorder (ages 0-45), siblings of children and adults with autism spectrum disorder (ages 0-45), and children and adults with developmental language delays (ages 0-45).

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00549731

Contacts

Contact: Alyssa Orinstein, Research Coordinator

617-766-9766

TRANSCEND@partners.org

Locations

United States, Massachusetts
Martinos Center of Biomedical Imaging	Recruiting
Charlestown, Massachusetts, United States, 02129

Sponsors and Collaborators

Massachusetts General Hospital

Investigators

Principal Investigator:	Martha Herbert, MD, Ph.D	Massachusetts General Hospital
Principal Investigator:	Tal Kenet, Ph.D	Massachusetts General Hospital
Principal Investigator:	Katherine Martien, MD	Massachusetts General Hospital/LADDERS

More Information

No publications provided

Responsible Party:	Massachusetts General Hospital ( Martha Herbert )
Study ID Numbers:	2007-P-000062
Study First Received:	October 15, 2007
Last Updated:	September 25, 2009
ClinicalTrials.gov Identifier:	NCT00549731 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:

autism
autistic
language

development
developmental
assessment

Additional relevant MeSH terms:

Disease
Nervous System Diseases
Language Development Disorders
Language Disorders
Child Development Disorders, Pervasive
Signs and Symptoms
Pathologic Processes

Autistic Disorder
Mental Disorders
Mental Disorders Diagnosed in Childhood
Neurologic Manifestations
Neurobehavioral Manifestations
Communication Disorders

ClinicalTrials.gov processed this record on November 27, 2009